Dae-Woong Cho
Algemeen Directeur bij CELLIVERY THERAPEUTICS, INC.
Vermogen: 26 M $ op 31-03-2023
Actieve functies van Dae-Woong Cho
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CELLIVERY THERAPEUTICS, INC. | Directeur/Bestuurslid | 28-08-2014 | - |
| Algemeen Directeur | 28-08-2014 | - | |
| Hoofd Techniek/Wetenschap/O&O | 28-08-2014 | - | |
| Oprichter | 14-03-2014 | - |
Loopbaan van Dae-Woong Cho
Eerdere bekende functies van Dae-Woong Cho
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
ProCell Therapeutics, Inc.
 ProCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ProCell Therapeutics, Inc. develops protein-based therapeutics. It handles the research and development of biotherapeutics capable of entering cells through proprietary Macromolecule Intracellcellular Transduction Technologies (MITT) using a line-up of Macromolecule Transduction Domain (MTD). The company was founded on December 12, 2005 and is headquartered in Seoul, South Korea. | Oprichter | 20-12-2005 | - |
| President | 09-04-2010 | - | |
| Chonnam National University | Corporate Officer/Principal | - | - |
| YUHAN CORPORATION | Corporate Officer/Principal | - | - |
GenoCheck Co., Ltd.
 GenoCheck Co., Ltd. Medical SpecialtiesHealth Technology GenoCheck Co., Ltd. is a holding company, which conducts research in biotechnology and offers products and services related to genes. Its activities include exploring and testing of genes related to human diseases, developing diagnostic deoxyribonucleic acid (DNA) chip and new drugs. The firm's products include microarray, ribonucleic acid stabilization solution, and DNA extraction kit. The company was founded on May 1, 2000 and is headquartered in Seoul, South Korea. | Corporate Officer/Principal | - | - |
| Vanderbilt University | Corporate Officer/Principal | - | - |
Opleiding van Dae-Woong Cho
| Vanderbilt University | Doctorate Degree |
| Hanyang University | Graduate Degree |
Statistieken
Internationaal
| Zuid-Korea | 7 |
| Verenigde Staten | 2 |
Operationeel
| Corporate Officer/Principal | 4 |
| Founder | 2 |
| Director/Board Member | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| CELLIVERY THERAPEUTICS, INC. | Health Technology |
| YUHAN CORPORATION | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
GenoCheck Co., Ltd.
GenoCheck Co., Ltd. Medical SpecialtiesHealth Technology GenoCheck Co., Ltd. is a holding company, which conducts research in biotechnology and offers products and services related to genes. Its activities include exploring and testing of genes related to human diseases, developing diagnostic deoxyribonucleic acid (DNA) chip and new drugs. The firm's products include microarray, ribonucleic acid stabilization solution, and DNA extraction kit. The company was founded on May 1, 2000 and is headquartered in Seoul, South Korea. | Health Technology |
ProCell Therapeutics, Inc.
ProCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ProCell Therapeutics, Inc. develops protein-based therapeutics. It handles the research and development of biotherapeutics capable of entering cells through proprietary Macromolecule Intracellcellular Transduction Technologies (MITT) using a line-up of Macromolecule Transduction Domain (MTD). The company was founded on December 12, 2005 and is headquartered in Seoul, South Korea. | Health Technology |
- Beurs
- Insiders
- Dae-Woong Cho
- Ervaring
